Biotronik SE & Co KG – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Biotronik SE & Co KG (Biotronik) is a medical device company that develops, manufactures and distributes cardiovascular and endovascular solutions. The company’s cardiac rhythm management solutions include implantable defibrillators, pacemakers and remote monitoring technologies used for the treatment of cardiac arrhythmias. Its electrophysiology products include heart catheters used to diagnose and treat cardiac arrhythmias; and vascular intervention products such as scaffolds, stents, balloon catheters and guide wires for the treatment of peripheral and coronary artery diseases. Biotronik has manufacturing facilities in Germany, Singapore, Switzerland and the US. The company markets products in Europe, North America, Latin America, Asia, Middle East, Oceania and Africa. Biotronik is headquartered in Berlin, Germany.

Biotronik SE & Co KG Key Recent Developments

Sep 24,2018: TCT Congress 2018: BIOTRONIK’s Orsiro Ultrathin Drug-Eluting Stent Further Outperforms Xience at Two-Year Follow-Up
Sep 14,2018: TOPC : Every Second Counts: BIOTRONIK’s PK Papyrus Stent for Coronary Perforations Approved for Use in the US[TPS : Biospace]
Aug 28,2018: InfoBionic Signs BIOTRONIK as Exclusive U.S. Distributor for MoMe Kardia
Aug 27,2018: BIOTRONIK Advances Arrhythmia Detection and Diagnosis with MoMe Cardiac Monitor in the US
Jun 21,2018: BIOTRONIK and GenesisCare Partner to Improve Heart Disease Therapy

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.